Cognizant recognized for its growing market adoption as a top pharmacovigilance operations leader in new everest group report

Teaneck, n.j., april 9, 2021 /prnewswire/ -- cognizant (nasdaq: ctsh) announced it has been named one of the leading companies in the pharmacovigilance market, offering an end-to-end spectrum of patient safety services in a new report by analyst firm everest group.
CTSH Ratings Summary
CTSH Quant Ranking